Edgen Stock·Sep 20 2025, 00:36戻る
戻る
Merck Receives Positive EU CHMP Opinion for RSV Preventive ENFLONSIA™
Edgen Stock·Sep 20 2025, 00:36
[1] Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season[2] European regulator recommends approval of Merck's RSV antibody - Investing.com UK[3] European regulator recommends approval of Merck's RSV antibody - Investing.com